University of Illinois Chicago - Chemistry
Senior Research Scientist at the Hungarian Academy of Sciences (institutional equivalent of professor)
Research
Gabriel
Fenteany
Szeged, Csongrád, Hungary
Throughout my career, my research has been at the interface of chemistry and biology. My main focus has been the application of the approaches of chemical biology to cell biology. Our efforts have resulted in the discovery of a range of novel small-molecule modulators of basic biological processes of medical significance, determination of their molecular targets and mechanisms of action, revealing new functions of those targets in biology, and dissection of cellular processes through multi-methodological approaches. An overarching theme of my whole research career has been the question of how specific molecular recognition and interaction events, one upon on another, ultimately give rise to higher-order function at the cellular level. Such interests have led me to study the dynamics of large protein complexes that are challenging to investigate but nevertheless amenable to dissection into smaller-scale contributing protein–protein interactions with chemical thinking and tools, from proteasome structure–function to cytoskeletal dynamics that generate various mechanical forces and now to my present work on ubiquitination and post-translational modification-dependent protein complex dynamics. A tremendous salutary benefit of such approaches is that the tools themselves can have immediate new therapeutic potential. I have mentored 8 post-doctoral fellows, 14 Ph.D. students, 6 master’s students, 18 undergraduates, two technicians, and two high school scholars. I have been the principal investigator on major grants from the National Institutes of Health, the American Cancer Society and other funding organizations.
Senior Research Scientist
Research and advising in the Division of Endocrinology, Data Sciences Research Center and Research Administration
Associate Professor
Research, advising, teaching, service
Senior Research Scientist
Research, advising
Life Sciences Research Foundation Postdoctoral Fellow
Research in biochemistry and cell biology
Assistant Professor
Research, advising, teaching, service
Licentiate degree
Biology
Exchange student from Reed College
Bachelor of Arts (B.A.), Master of Arts (M.A.)
Biochemistry, Aquatic Biology
Research in biochemistry, molecular biology and marine biology
Doctor of Philosophy (Ph.D.)
Biochemistry
Research in bioorganic chemistry and chemical biology, teaching
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Case Rep. Endocrinol.
Powell, D.; Inoue, T.; Bahtiyar, G.; Fenteany, G; Sacerdote, A. Treatment of nonclassic 11-hydroxylase deficiency with Ashwagandha root. Case Rep. Endocrinol. 2017, Article ID 1869560.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Case Rep. Endocrinol.
Powell, D.; Inoue, T.; Bahtiyar, G.; Fenteany, G; Sacerdote, A. Treatment of nonclassic 11-hydroxylase deficiency with Ashwagandha root. Case Rep. Endocrinol. 2017, Article ID 1869560.
J. Phys. Chem. B
Rudnitskaya, A.N; Eddy, N; Fenteany, G; Gascón, J.A. Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin. J. Phys. Chem. B. 2012, 116, 10176-10181.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Case Rep. Endocrinol.
Powell, D.; Inoue, T.; Bahtiyar, G.; Fenteany, G; Sacerdote, A. Treatment of nonclassic 11-hydroxylase deficiency with Ashwagandha root. Case Rep. Endocrinol. 2017, Article ID 1869560.
J. Phys. Chem. B
Rudnitskaya, A.N; Eddy, N; Fenteany, G; Gascón, J.A. Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin. J. Phys. Chem. B. 2012, 116, 10176-10181.
Cytoskeleton
Clark, A.G.; Sider, J.R.; Verbrugghe, K.; Fenteany, G.; von Dassow, G.; Bement, W.M. Identification of small molecule inhibitors of cytokinesis and single cell wound repair. Cytoskeleton. 2012, 11, 1010-1020.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Case Rep. Endocrinol.
Powell, D.; Inoue, T.; Bahtiyar, G.; Fenteany, G; Sacerdote, A. Treatment of nonclassic 11-hydroxylase deficiency with Ashwagandha root. Case Rep. Endocrinol. 2017, Article ID 1869560.
J. Phys. Chem. B
Rudnitskaya, A.N; Eddy, N; Fenteany, G; Gascón, J.A. Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin. J. Phys. Chem. B. 2012, 116, 10176-10181.
Cytoskeleton
Clark, A.G.; Sider, J.R.; Verbrugghe, K.; Fenteany, G.; von Dassow, G.; Bement, W.M. Identification of small molecule inhibitors of cytokinesis and single cell wound repair. Cytoskeleton. 2012, 11, 1010-1020.
J. Med. Case Rep.
Fenteany, G.; Inoue, T.; Bahtiyar, G.; Sacerdote, A. Association of vitamin D repletion with normalization of elevated serum 17-OH progesterone. J. Med. Case Rep., 2017, 3, 22.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Case Rep. Endocrinol.
Powell, D.; Inoue, T.; Bahtiyar, G.; Fenteany, G; Sacerdote, A. Treatment of nonclassic 11-hydroxylase deficiency with Ashwagandha root. Case Rep. Endocrinol. 2017, Article ID 1869560.
J. Phys. Chem. B
Rudnitskaya, A.N; Eddy, N; Fenteany, G; Gascón, J.A. Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin. J. Phys. Chem. B. 2012, 116, 10176-10181.
Cytoskeleton
Clark, A.G.; Sider, J.R.; Verbrugghe, K.; Fenteany, G.; von Dassow, G.; Bement, W.M. Identification of small molecule inhibitors of cytokinesis and single cell wound repair. Cytoskeleton. 2012, 11, 1010-1020.
J. Med. Case Rep.
Fenteany, G.; Inoue, T.; Bahtiyar, G.; Sacerdote, A. Association of vitamin D repletion with normalization of elevated serum 17-OH progesterone. J. Med. Case Rep., 2017, 3, 22.
Eur. J. Org. Chem.
Eddy, N.A.; Richardson, J.J.; Fenteany, G. The effect of Lewis acids on the cycloaddition of 3,3,6-trimethylcyclohex-5-ene-1,2,4-trione: hydrogen transfer versus cycloaddition with cyclopentadiene. Eur. J. Org. Chem. 2013, 2013 (23), 5041-5044
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Case Rep. Endocrinol.
Powell, D.; Inoue, T.; Bahtiyar, G.; Fenteany, G; Sacerdote, A. Treatment of nonclassic 11-hydroxylase deficiency with Ashwagandha root. Case Rep. Endocrinol. 2017, Article ID 1869560.
J. Phys. Chem. B
Rudnitskaya, A.N; Eddy, N; Fenteany, G; Gascón, J.A. Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin. J. Phys. Chem. B. 2012, 116, 10176-10181.
Cytoskeleton
Clark, A.G.; Sider, J.R.; Verbrugghe, K.; Fenteany, G.; von Dassow, G.; Bement, W.M. Identification of small molecule inhibitors of cytokinesis and single cell wound repair. Cytoskeleton. 2012, 11, 1010-1020.
J. Med. Case Rep.
Fenteany, G.; Inoue, T.; Bahtiyar, G.; Sacerdote, A. Association of vitamin D repletion with normalization of elevated serum 17-OH progesterone. J. Med. Case Rep., 2017, 3, 22.
Eur. J. Org. Chem.
Eddy, N.A.; Richardson, J.J.; Fenteany, G. The effect of Lewis acids on the cycloaddition of 3,3,6-trimethylcyclohex-5-ene-1,2,4-trione: hydrogen transfer versus cycloaddition with cyclopentadiene. Eur. J. Org. Chem. 2013, 2013 (23), 5041-5044
Forum Immunopath. Dis. Ther.
Beshir, A.B.; Argueta, C.E.; Menikarachchi, L.C.; Gascón, J.A.; Fenteany, G. Locostatin disrupts association of Raf kinase inhibitor protein with binding proteins by modifying a conserved histidine residue in the ligand-binding pocket. Forum Immunopath. Dis. Ther. 2011, 2, 47-58.
Cancer Res.
Ren, G.; Baritaki, S.; Marathe, H.; Feng, J.; Park, S.; Beach, S.; Bazeley, P.S.; Beshir, A.B.; Fenteany, G.; Mehra, R.; Daignault, S.; Al Mulla, F.; Keller, E.; Bonavida, B.; de la Serna, I.; Yeung, K.C. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer. Res. 2012, 72, 3091-3104.
Org. Lett.
Eddy, N.A.; Kelly, C.B.; Mercadante, M.A.; Leadbeater, N.E.; Fenteany, G. Access to dienophilic ene-triketone synthons by oxidation of diketones with an oxoammonium salt. Org. Lett. 2012, 14, 498–501.
Chem. Eur. J.
Wang, Z.; Castellano, S.; Kinderman, S.S.; Argueta, C.E.; Beshir, A.B.; Fenteany, G.; Kwon, O. Diversity through a branched reaction pathway: generation of a library of sixteen multicyclic scaffolds and identification of antimigratory agents. Chem. Eur. J. 2011, 17, 649-654.
Case Rep. Endocrinol.
Powell, D.; Inoue, T.; Bahtiyar, G.; Fenteany, G; Sacerdote, A. Treatment of nonclassic 11-hydroxylase deficiency with Ashwagandha root. Case Rep. Endocrinol. 2017, Article ID 1869560.
J. Phys. Chem. B
Rudnitskaya, A.N; Eddy, N; Fenteany, G; Gascón, J.A. Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin. J. Phys. Chem. B. 2012, 116, 10176-10181.
Cytoskeleton
Clark, A.G.; Sider, J.R.; Verbrugghe, K.; Fenteany, G.; von Dassow, G.; Bement, W.M. Identification of small molecule inhibitors of cytokinesis and single cell wound repair. Cytoskeleton. 2012, 11, 1010-1020.
J. Med. Case Rep.
Fenteany, G.; Inoue, T.; Bahtiyar, G.; Sacerdote, A. Association of vitamin D repletion with normalization of elevated serum 17-OH progesterone. J. Med. Case Rep., 2017, 3, 22.
Eur. J. Org. Chem.
Eddy, N.A.; Richardson, J.J.; Fenteany, G. The effect of Lewis acids on the cycloaddition of 3,3,6-trimethylcyclohex-5-ene-1,2,4-trione: hydrogen transfer versus cycloaddition with cyclopentadiene. Eur. J. Org. Chem. 2013, 2013 (23), 5041-5044
Forum Immunopath. Dis. Ther.
Beshir, A.B.; Argueta, C.E.; Menikarachchi, L.C.; Gascón, J.A.; Fenteany, G. Locostatin disrupts association of Raf kinase inhibitor protein with binding proteins by modifying a conserved histidine residue in the ligand-binding pocket. Forum Immunopath. Dis. Ther. 2011, 2, 47-58.
ACS Chem. Biol.
Magpusao, A.N.; Omolloh, G.; Johnson, J.; Gascón, J.; Peczuh, M.W.; Fenteany, G. Cardiac glycoside activities link Na(+)/K(+) ATPase ion-transport to breast cancer cell migration via correlative SAR. ACS Chem. Biol.. 2015, 10, 561-569.